指南与共识乳腺技术与安全CTMRPET

基于现代影像与转移导向治疗设计少转移性乳腺癌临床试验:EORTC影像与乳腺癌组的共识推荐

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
指南 / 共识 · Lancet Oncol · 2023-01-01

欧洲癌症研究与治疗组织影像与乳腺癌组的35位专家,在全面文献回顾基础上通过德尔菲问卷形成共识推荐,涵盖少转移性乳腺癌定义、最佳诊断路径及评估影像策略与转移导向治疗的临床试验设计;主要推荐包括在转移筛查中引入现代影像方法以更早诊断少转移性乳腺癌,并开展兼顾乳腺癌组织学与分子复杂性的前瞻性试验。

要点

  • 推荐在转移筛查中引入现代影像方法,以更早诊断少转移性乳腺癌。
  • 少转移性乳腺癌的定义应纳入组织学与分子异质性,而非仅凭转移灶数目。
  • 需开展前瞻性试验评估影像策略与转移导向治疗在不同患者亚组中的效果。

核心结论

  • 主要推荐为在转移筛查中引入现代影像方法以更早诊断少转移性乳腺癌,并开展兼顾乳腺癌组织学与分子复杂性的前瞻性试验。
  • 共识还涉及少转移性乳腺癌定义、最佳诊断路径、评估诊断影像策略与转移导向治疗效果的临床试验,以及不同患者亚组中影像方法与治疗策略的随机化方案。

研究设计与样本

  • 欧洲癌症研究与治疗组织影像与乳腺癌组的35位专家,在全面文献回顾后制定德尔菲问卷以形成共识推荐。
  • 共识内容涵盖少转移性乳腺癌定义、最佳诊断路径及评估诊断影像策略与转移导向治疗效果的临床试验。

诊断标准与关键数值

  • 共识推荐在转移筛查中引入现代影像方法,以更早诊断少转移性乳腺癌。
  • 共识推荐开展前瞻性试验,并兼顾乳腺癌的组织学与分子复杂性。
  • 共识涉及不同患者亚组中影像方法与治疗策略的随机化策略。

临床应用与阅片要点

  • 原文未据此给出针对日常阅片与报告的具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Breast cancer remains the most common cause of cancer death among women. Despite its considerable histological and molecular heterogeneity, those characteristics are not distinguished in most definitions of oligometastatic disease and clinical trials of oligometastatic breast cancer. After an exhaustive review of the literature covering all aspects of oligometastatic breast cancer, 35 experts from the European Organisation for Research and Treatment of Cancer Imaging and Breast Cancer Groups elaborated a Delphi questionnaire aimed at offering consensus recommendations, including oligometastatic breast cancer definition, optimal diagnostic pathways, and clinical trials required to evaluate the effect of diagnostic imaging strategies and metastasis-directed therapies. The main recommendations are the introduction of modern imaging methods in metastatic screening for an earlier diagnosis of oligometastatic breast cancer and the development of prospective trials also considering the histological and molecular complexity of breast cancer. Strategies for the randomisation of imaging methods and therapeutic approaches in different subsets of patients are also addressed.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Pasquier D, Bidaut L, Oprea-Lager DE, et al. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups. Lancet Oncol. 2023. PMID: 37541279. doi:10.1016/S1470-2045(23)00286-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。